**3. Conclusion**

In summary, ovarian cancer is a heterogeneous spectrum of disease. Early detection and accurate staging using diagnostic imaging can help improve the prognosis of this condition. Prudent selection of the appropriate imaging modality can help expedite the correct treatment being instituted for the patients (**Table 3**). Molecular imaging, particularly 18F-FDG PET/CT can be a useful non-invasive biomarker to help stage the disease and detect recurrence based on the proposed diagnostic algorithm in this chapter.


**Table 3.** Comparison of the diagnostic imaging modalities for the management of ovarian cancer.
